Effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy: the Rosiglitazone Early Versus SULphonylurea Titration (RESULT) Study.
Where this comes from
- Record sourced from PubMed, PMID 20048503.
- Also identified by DOI 10.3810/psm.2009.04.1698.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Practice Pearl: This study demonstrates the effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy. Original Article: Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
Medical subject headings
- Diabetes Mellitus, Type 2
- Glipizide
- Hypoglycemic Agents
- Thiazolidinediones